This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Under $10 Poised for Breakouts


One under-$10 stock in the biotechnology and drugs complex that's trading very close to triggering a near-term breakout trade is TrovaGene (TROV), a development stage molecular diagnostic company focused on developing and marketing urine-based nucleic acid tests for patient/disease screening and monitoring in the U.S. This stock has been smacked by the sellers so far in 2012, with shares down by over 25%.

If you take a look at the chart for TrovaGene, you'll notice that this stock formed a double-bottom chart pattern back in late August at around $2.11 to $2.09 a share. Following that bottom, shares of TROV have started to soar and move within range of triggering a near-term breakout trade. The recent spike which has pushed the stock above $2.70 a share has also moved TROV within range of taking out its 200-day moving average of $2.86 a share.

>>5 Technical Trades Under $10

Traders should now look for long-biased trades in TROV once it breaks out above some near-term overhead resistance at $2.86 a share with high volume. Look for a sustained move or close above $2.86 a share with volume that hits near or above its three-month average action of 56,492 shares. If that breakout triggers soon, TROV will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at its 200-day moving average of $3.78 a share, or possibly even $4 to $4.24 a share.

Traders can now look to buy TROV off any weakness to anticipate that breakout and simply use a stop that sits just below some near-term support at $2.46 a share. One could also buy off strength once TROV takes out $2.86 a share with volume and then simply use that same stop below $2.46 a share.

2 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,042.93 -28.29 -0.17%
S&P 500 1,975.20 -2.60 -0.13%
NASDAQ 4,498.9960 -6.8560 -0.15%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs